Retatrutide

Retatrutide is an investigational peptide engineered to activate three metabolic receptor systems: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptors. This multi-agonist profile makes it a valuable research tool for studying appetite regulation, glucose-responsive insulin signaling, energy expenditure, lipid metabolism and body-weight regulation. Clinical research has examined its effects on metabolic outcomes, while laboratory work continues to investigate how the balance of activity at each receptor contributes to its overall pharmacology. Retatrutide is especially relevant for comparative studies involving single-, dual- and triple-incretin receptor agonists, receptor selectivity, downstream second-messenger activity and metabolic biomarker responses. It should be handled as an investigational research material rather than presented as an established therapy.

For laboratory research use only. Not for human or veterinary use. This description is informational and does not provide medical advice, dosing, or treatment guidance.